Artificial Insemination Market To Reach $4.01 Billion By 2030

Artificial Insemination Market Growth & Trends

The global artificial insemination market size is expected to reach USD 4.01 billion by 2030 registering a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.

Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).

 Request a free sample copy or view report summary: Artificial Insemination Market Report

Artificial Insemination Market Report Highlights

• Intrauterine insemination (IUI) dominated the market with 71.7% of revenue share in 2023. This is due to its relatively simple procedure, minimal invasiveness, and effectiveness in treating various infertility issues.

• AIH-Husband dominated the market with 66.8% of revenue share in 2023. This is due to the increasing awareness and acceptance of assisted reproductive technologies among couples facing infertility challenges.

• Fertility clinics & others dominated the market with 53.2% share in 2023. These clinics offer a controlled environment with experienced medical professionals to perform the procedure, maximizing its effectiveness.

• Asia Pacific artificial insemination market dominated the market with 30.1% share in 2023. This growth is attributed to the rising number of infertile couples and technological advancements in the fertility segment.

Artificial Insemination Market Segmentation

Grand View Research has segmented the global artificial insemination market on the basis of type, source, end use, and region

Artificial Insemination Type Outlook (Revenue, USD Million, 2018 - 2030)

• Intrauterine Insemination

• Intracervical Insemination

• Intravaginal Insemination

• Intratubal Insemination

Artificial Insemination Source Outlook (Revenue, USD Million, 2018 - 2030)

• AIH-Husband

• AID-Donor

Artificial Insemination End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Fertility clinics & other facilities

• Home

Artificial Insemination Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Mexico

  • Canada

• Europe

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Thailand

  • Australia

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Artificial Insemination Market

• Vitrolife

• Genea Pty Limited

• Rinovum Women’s Health, LLC

• Pride Angel

• HI-TECH SOLUTIONS

• FUJIFILM Irvine Scientific

• Kitazato Corporation

• Rocket Medical plc

• Conceivex, Inc.